Nusinersen for SMA

from JNNP Podcast · host BMJ Group

Elizabeth Highton (JNNP Podcast Editor) speaks with Dr. Michelle Farrar (University of New South Wales) discussing nusinersen, the first disease-modifying therapy for spinal muscular atrophy type 1 (SMA). https://jnnp.bmj.com/content/89/9/937

Episode metadata supplied by the publisher feed · Published Aug 29, 2018

Embed this episode

Attribution link and audio player

Ready to play

Nusinersen for SMA

0:00 10:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JNNP Podcast?

This episode is 10 minutes long.

When was this JNNP Podcast episode published?

This episode was published on August 29, 2018.

Can I download this JNNP Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!